Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Revenue (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Revenue data on record, last reported at $373.9 million in Q4 2025.

  • For Q4 2025, Revenue rose 20.9% year-over-year to $373.9 million; the TTM value through Dec 2025 reached $1.5 billion, up 32.39%, while the annual FY2025 figure was $1.3 billion, 27.37% up from the prior year.
  • Revenue reached $373.9 million in Q4 2025 per PAHC's latest filing, up from $363.9 million in the prior quarter.
  • Across five years, Revenue topped out at $378.7 million in Q2 2025 and bottomed at $211.7 million in Q1 2021.
  • Average Revenue over 5 years is $270.2 million, with a median of $252.5 million recorded in 2023.
  • Peak YoY movement for Revenue: decreased 0.5% in 2023, then surged 39.73% in 2025.
  • A 5-year view of Revenue shows it stood at $232.7 million in 2021, then grew by 5.13% to $244.6 million in 2022, then rose by 2.17% to $249.9 million in 2023, then increased by 23.73% to $309.3 million in 2024, then increased by 20.9% to $373.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $373.9 million in Q4 2025, $363.9 million in Q3 2025, and $378.7 million in Q2 2025.